{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:09Z","timestamp":1761513249534},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00520-013-1753-3","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T05:25:03Z","timestamp":1360733103000},"page":"1879-1884","source":"Crossref","is-referenced-by-count":7,"title":["Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma"],"prefix":"10.1007","volume":"21","author":[{"given":"Steven C.","family":"Kao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Corte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janette","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"1753_CR1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644","journal-title":"J Clin Oncol"},{"key":"1753_CR2","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"JP Meerbeeck van","year":"2005","unstructured":"van Meerbeeck JP, Gaafar R, Manegold C, van Klaveren RJ, van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Glaccone G, European Organisation for Research and Treatment of Cancer Lung Cancer Group, National Cancer Institute of Canada (2005) Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 23:6881\u20136889","journal-title":"J Clin Oncol"},{"key":"1753_CR3","first-page":"513","volume-title":"Oxford textbook of palliative Medicine","author":"M McIllmurray","year":"2010","unstructured":"McIllmurray M (2010) The medical treatment of cancer in palliative care. In: Hanks G, Cherny N, Christakis N, Fallon M, Kaasa S, Portenov R (eds) Oxford textbook of palliative Medicine, 4th edn. Oxford University Press, New York, pp 513\u2013525","edition":"4"},{"key":"1753_CR4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","volume":"371","author":"MF Muers","year":"2008","unstructured":"Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, Nicholson AG, O'Brien M, Peake M, Rudd R, Snee M, Steele J, Girling DJ, Nankivell M, Pugh C, Parmar MK, MS01 Trial Management Group (2008) Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 371:1685\u20131694","journal-title":"Lancet"},{"key":"1753_CR5","volume-title":"Mesothelioma in Australia: incidence 1982 to 2007, Mortality 1997 to 2007","author":"SW Australia","year":"2011","unstructured":"Australia SW (2011) Mesothelioma in Australia: incidence 1982 to 2007, Mortality 1997 to 2007. Commonwealth of Australia, Canberra"},{"key":"1753_CR6","doi-asserted-by":"crossref","unstructured":"Kao S, Clarke S, Vardy J, Corte P, Clarke C, van Zandwijk N (2012) Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales of Australia. Intern Med J. doi: 10.1111\/j.1445-5994.2012.02925.x","DOI":"10.1111\/j.1445-5994.2012.02925.x"},{"key":"1753_CR7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1089\/jpm.2006.0259","volume":"10","author":"N Fadul","year":"2007","unstructured":"Fadul N, Elsayem A, Palmer JL, Zhang T, Braiteh F, Bruera E (2007) Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med 10:1146\u20131152","journal-title":"J Palliat Med"},{"key":"1753_CR8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/annonc\/mdp027","volume":"20","author":"S Kao","year":"2009","unstructured":"Kao S, Shafiq J, Vardy J, Adams D (2009) Use of chemotherapy at end of life in oncology patients. Ann Oncol 20:1555\u20131559","journal-title":"Ann Oncol"},{"key":"1753_CR9","doi-asserted-by":"crossref","unstructured":"Nappa U, Lindqvist O, Rasmussen B, Axelsson B (2011) Palliative chemotherapy during the last month of life. Ann Oncol. doi: 10.1093\/annonc\/mdq778","DOI":"10.1093\/annonc\/mdq778"},{"key":"1753_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1200\/JCO.2004.08.136","volume":"22","author":"C Earle","year":"2004","unstructured":"Earle C, Neville B, Landrum M, Ayanian J, Block S, Weeks J (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315\u2013321","journal-title":"J Clin Oncol"},{"key":"1753_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-138-8-200304150-00011","volume":"138","author":"E Emanuel","year":"2003","unstructured":"Emanuel E, Young-Xu Y, Levinsky N, Gazelle G, Saynina O, Ash A (2003) Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 138:639\u2013643","journal-title":"Ann Intern Med"},{"key":"1753_CR12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/theoncologist.11-10-1095","volume":"11","author":"JJ Murillo","year":"2006","unstructured":"Murillo JJ, Koeller J (2006) Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Oncologist 11:1095\u20131099","journal-title":"Oncologist"},{"key":"1753_CR13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1200\/JCO.2003.03.059","volume":"21","author":"C Earle","year":"2003","unstructured":"Earle C, Park E, Lai B, Weeks J, Ayanian J, Block S (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133\u20131138","journal-title":"J Clin Oncol"},{"key":"1753_CR14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/082585970602200103","volume":"22","author":"L Barbera","year":"2006","unstructured":"Barbera L, Paszat L, Chartier C (2006) Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care 22:12\u201317","journal-title":"J Palliat Care"},{"key":"1753_CR15","doi-asserted-by":"crossref","unstructured":"Kao S, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S (2012) Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clin Lung Cancer. doi: 10.1016\/j.cllc.2012.03.011","DOI":"10.1016\/j.cllc.2012.03.011"},{"key":"1753_CR16","volume-title":"ASGC Remoteness Classification: purpose and use (Census Paper No. 03\/01)","author":"Australian Bureau of Statistics","year":"2003","unstructured":"Australian Bureau of Statistics (2003) ASGC Remoteness Classification: purpose and use (Census Paper No. 03\/01). Commonwealth of Australia, Canberra"},{"key":"1753_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6601957","volume":"91","author":"S Bydder","year":"2004","unstructured":"Bydder S, Phillips M, Joseph DJ, Cameron F, Spry NA, DeMelker Y, Musk AW (2004) A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 91:9\u201310","journal-title":"Br J Cancer"},{"key":"1753_CR18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","volume":"108","author":"C Boutin","year":"1995","unstructured":"Boutin C, Rey F, Viallat J-R (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. Chest 108:754\u2013758","journal-title":"Chest"},{"key":"1753_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2007.05.022","volume":"84","author":"N O'Rourke","year":"2007","unstructured":"O'Rourke N, Garcia JC, Paul J, Lawless C, McMenemin R, Hill J (2007) A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 84:18\u201322","journal-title":"Radiother Oncol"},{"key":"1753_CR20","volume-title":"Lack of response to vinorelbine in patients with previously treated malignant pleural mesothleioma (MPM): rational for placebo-controlled trials in the 2nd line setting","author":"MG Zauderer","year":"2012","unstructured":"Zauderer MG, Sima CS, Ginsberg MS, Krug LM (2012) Lack of response to vinorelbine in patients with previously treated malignant pleural mesothleioma (MPM): rational for placebo-controlled trials in the 2nd line setting. 11th International Conference of the International Mesothelioma Interest Group, Boston, Abstr IB.7"},{"key":"1753_CR21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"J Temel","year":"2010","unstructured":"Temel J, Greer J, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Piri WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733\u2013742","journal-title":"N Engl J Med"},{"key":"1753_CR22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","volume":"135","author":"RM Flores","year":"2008","unstructured":"Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW (2008) Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620\u2013625","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1753_CR23","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","volume":"26","author":"CC Earle","year":"2008","unstructured":"Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860\u20133866","journal-title":"J Clin Oncol"},{"key":"1753_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1322-7696(08)60451-5","volume":"11","author":"R Hawley","year":"2004","unstructured":"Hawley R, Monk A (2004) Malignant mesothelioma: current practice and research directions. Collegian 11:22\u201326","journal-title":"Collegian"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-1753-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1753-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:29:30Z","timestamp":1562693370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-1753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-1753-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}